financetom
Business
financetom
/
Business
/
Why Home-Furnishing Retailer RH Shares Are Gaining Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Home-Furnishing Retailer RH Shares Are Gaining Today
Mar 28, 2024 5:12 AM

RH shares are trading higher in the premarket session on Thursday.

Yesterday, the company reported fourth-quarter results, where revenues of $738.26 million missed the consensus estimate of $777.48 million.

Revenue was negatively impacted by $40 million in the fourth quarter due to the severe January weather and shipping delays related to the ongoing conflict in the Red Sea. 

Read More: RH Q4 Earnings: Revenue Miss, EPS Miss, Upbeat Guidance On Accelerating Demand Trends And More

Despite the revenue miss, RH disclosed solid expansion plans for 2024, with focus on advertising.

The company expects to open five North American Design Galleries, including Cleveland, which opened last week, Palo Alto, Raleigh, Newport Beach, and Montecito, all with RH Interior Design Offices, restaurants, and wine bars. 

RH said it will also be opening two international galleries, one in Brussels, which opened last week, and one in Madrid, which will open this summer. 

RH plans to increase print and digital advertising across major home design publications in 2024. 

The company’s ads will be seen in Architectural Digest, Elle Decor, Veranda, Gallerie, World of Interiors, Luxe Interiors and Design, Business of Home, The Financial Times, The Wall Street Journal, and T Magazine design issues. 

“We do expect the majority of the deferred revenue will be realized in 2024 when transit times normalize,” RH said in a press release.  

Overall, the company expects demand trends to accelerate throughout fiscal 2024. 

However, RH expects business conditions to remain challenging until interest rates ease and the housing market begins to rebound. 

RH said it is forecasting first-quarter demand growth to be in the mid-single digit range, while revenues are expected to be down in the low-single digits. Adjusted operating margin is expected to be in the range of 6% to 7%, and adjusted EBITDA margin is expected to be in the range of 12% to 13%. 

RH sees full-year 2024 demand growth of 12% to 14% and revenue growth of 8% to 10% on a year-over-year basis. 

Full year adjusted operating margin is expected to be in the range of 13% to 14% and adjusted EBITDA margin is expected to be in the range of 18% to 19%. 

According to Benzinga Pro, RH stock has gained over 23% in the past year. Investors can gain exposure to the stock via Tidal ETF Trust II The Meet Kevin Pricing Power ETF .

Price Action: RH shares are trading higher by 9.43% to $325.00 premarket on the last check Thursday. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Dec 16, 2024
08:39 AM EST, 12/16/2024 (MT Newswires) -- Consumer shares were advancing pre-bell Monday with the Consumer Staples Select Sector SPDR Fund (XLP) marginally up and the Consumer Discretionary Select Sector SPDR Fund (XLY) 0.5% higher recently. Alibaba Group Holding ( BABA ) is nearing an agreement to sell its department store business Intime to Youngor Fashion for roughly $1 billion,...
Market Chatter: Berkshire Hills, Brookline in Merger Talks
Market Chatter: Berkshire Hills, Brookline in Merger Talks
Dec 16, 2024
08:37 AM EST, 12/16/2024 (MT Newswires) -- Berkshire Hills Bancorp ( BHLB ) and Brookline Bancorp ( BRKL ) are in talks to merge, the Wall Street Journal reported Monday, citing people familiar with the matter. A deal could be finalized as early as next week, according to the report. Each regional bank holds about $12 billion in assets and...
Innoviva to Sell Basilea Pharmaceutica's MRSA Antibiotic Zevtera in US Under Exclusive Deal
Innoviva to Sell Basilea Pharmaceutica's MRSA Antibiotic Zevtera in US Under Exclusive Deal
Dec 16, 2024
08:40 AM EST, 12/16/2024 (MT Newswires) -- Innoviva ( INVA ) unit Innoviva Specialty Therapeutics said Monday it signed an exclusive licensing and distribution deal with Basilea Pharmaceutica for US marketing rights to the antibiotic Zevtera or ceftobiprole. The company, which plans to launch Zevtera in the US by mid-2025, said it will pay Basilea $4 million upfront, with additional...
Mind Medicine Doses First Patient in Phase 3 Study of MM120 to Treat Generalized Anxiety Disorder
Mind Medicine Doses First Patient in Phase 3 Study of MM120 to Treat Generalized Anxiety Disorder
Dec 16, 2024
08:35 AM EST, 12/16/2024 (MT Newswires) -- Mind Medicine (MNMD) said Monday that a first patient has been dosed in its phase 3 Voyage study that is evaluating MM120 ODT for the treatment of generalized anxiety disorder. The company said the trial is the first of two phase 3 studies evaluating the efficacy and safety of MM120 ODT versus placebo....
Copyright 2023-2026 - www.financetom.com All Rights Reserved